Current options for the treatment of Paget&rsquo;s disease of the bone

Código QR

Current options for the treatment of Paget&rsquo;s disease of the bone

Daniela Merlotti, Luigi Gennari, Giuseppe Martini, Ranuccio NutiDepartment of Internal Medicine, Endocrine-Metabolic Sciences and Biochemistry, University of Siena, Siena, ItalyAbstract: Paget&rsquo;s disease of bone (PDB) is a chronic bone remodeling disorder characterized by increased oste...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Daniela Merlotti, Luigi Gennari, Giuseppe Martini, et al
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2009
Materias:	Diseases of the musculoskeletal system RC925-935
Acceso en línea:	https://doaj.org/article/179fc24e58804a3f81759e11b5ebfdac
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
por: Jill M Recla
Publicado: (2010)

Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
por: Ali Gur, et al.
Publicado: (2009)

Subclinical cerebrovascular cognitive function,&nbsp;and mood changes in patients with systemic&nbsp; lupus erythematosus
por: Ghaydaa A Shehata, et al.
Publicado: (2010)

Update on the diagnosis and management of Behçet’s disease
por: Rokutanda R, et al.
Publicado: (2014)

Incidence density of serious infection, opportunistic infection, and tuberculosis associated with biologic treatment in patients with rheumatoid arthritis &ndash; a systematic evaluation of the literature
por: Tran TN, et al.
Publicado: (2013)

Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
por: Fabrizio Cantini, et al.
Publicado: (2009)

Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis
por: Michihito Sato, et al.
Publicado: (2011)

Intrasound therapy in tendon healing: is intensity a factor?
por: AI Aiyegbusi, et al.
Publicado: (2010)

Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis
por: Takeo Isozaki, et al.
Publicado: (2010)

The epidemiology and treatment of gout
por: McGill NW
Publicado: (2011)

Basic fibroblast growth factor induces matrix metalloproteinase-13 via ERK MAP kinase-altered phosphorylation and sumoylation of Elk-1 in human adult articular chondrocytes
por: Hee-Jeong Im, et al.
Publicado: (2009)

Increased serum levels of macrophage migration inhibitory factor (MIF) in patients with microscopic polyangiitis
por: Hirohito Kanemitsu, et al.
Publicado: (2009)

A suppressive effect of prostaglandin E2 on the expression of SERPINE1/plasminogen activator inhibitor-1 in human articular chondrocytes: An in vitro pilot study
por: Kayo Masuko, et al.
Publicado: (2009)

Rheumatoid arthritis: Disease or syndrome?
por: Jessica A Stanich, et al.
Publicado: (2009)

Treatment of systemic-onset juvenile arthritis with canakinumab
por: Peitz J, et al.
Publicado: (2015)

Certolizumab in the long-term treatment of rheumatoid arthritis
por: Scott DL, et al.
Publicado: (2011)

Optimal dose of etanercept in the treatment of rheumatoid arthritis
por: Curtis EM, et al.
Publicado: (2014)

Tocilizumab in the treatment of systemic juvenile idiopathic arthritis
por: Murakami M, et al.
Publicado: (2012)

Long-term treatment of rheumatoid arthritis with adalimumab
por: Murdaca G, et al.
Publicado: (2013)

New and emerging therapies for the treatment of rheumatoid arthritis
por: Michael G Feely
Publicado: (2010)

Calcium pyrophosphate crystal deposition disease: diagnosis and treatment
por: Rosales-Alexander JL, et al.
Publicado: (2014)

Retrospective analysis of treatment modalities in diabetic muscle infarction
por: Onyenemezu I, et al.
Publicado: (2014)

Long-term use of adalimumab in the treatment of rheumatic diseases
por: Charalampos Papagoras, et al.
Publicado: (2009)

New developments in the treatment of osteoarthritis – focus on biologic agents
por: Torrero JI, et al.
Publicado: (2015)

Profile of ustekinumab and its potential in the treatment of active psoriatic arthritis
por: Montepaone M, et al.
Publicado: (2014)

Critical appraisal of efficacy and safety of abatacept in the treatment of refractory rheumatoid arthritis
por: Augustine JM, et al.
Publicado: (2012)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
por: Mysler E, et al.
Publicado: (2021)

Anakinra and related drugs targeting interleukin-1 in the treatment of cryopyrin- associated periodic syndromes
por: Bachove I, et al.
Publicado: (2014)

Interleukin-1 antagonists in the treatment of autoinflammatory syndromes, including cryopyrin-associated periodic syndrome
por: Pierre Quartier
Publicado: (2011)

A measure of treatment response: patient and physician satisfaction with traditional NSAIDs for osteoarthritis control
por: Taylor SD, et al.
Publicado: (2013)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
por: Masahiko Mihara, et al.
Publicado: (2011)

Efficacy and Safety of Etanercept Biosimilars Compared With the Originator for Treatment of Juvenile Arthritis: A Prospective Observational Study
por: Franz Thiele, et al.
Publicado: (2021)

Correction to: Treatment response and several patient-reported outcomes are early determinants of future self-efficacy in rheumatoid arthritis
por: Michaël Doumen, et al.
Publicado: (2021)

Intra-articular corticosteroids in the treatment of juvenile idiopathic arthritis: Safety, efficacy, and features affecting outcome. A comprehensive review of the literature
por: Alisa Carman Gotte
Publicado: (2009)

Patient and clinician experiences and opinions of the use of a novel home use medical device in the treatment of peripheral vascular disease - a qualitative study
por: Charlotte E. Sedgwick, et al.
Publicado: (2021)

The clinical efficacy and safety of certolizumab pegol (CZP) in the treatment of rheumatoid arthritis: focus on long-term use, patient considerations and the impact on quality of life
por: Roy Fleischmann
Publicado: (2009)

Single-cell expression quantitative trait loci (eQTL) analysis of SLE-risk loci in lupus patient monocytes
por: Yogita Ghodke-Puranik, et al.
Publicado: (2021)

Therapeutic apheresis in autoimmune diseases
por: Bambauer R, et al.
Publicado: (2013)

Recent advances in neutralizing the IL-6 pathway in arthritis
por: Charles J Malemud
Publicado: (2009)

Goals for rheumatoid arthritis: treating to target or treating to prevent?
por: Yang M, et al.
Publicado: (2012)